'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
LACTOSE (INDIA) LTD.
LACTOSE (BSE 524202) · ISIN INE058I01013 · Pharmaceuticals · Est. 1991 · listed 1992 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹64.79 cr | ₹61.66 cr | ₹183.23 cr |
| 30 Sep 2025 standalone | ₹62.4 cr | ₹52.87 cr | ₹137.81 cr |
| 31 Mar 2025 standalone | ₹58.74 cr | ₹56.19 cr | ₹133.47 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 53.65% | — | 0.62% | 46.35% |
Latest filings
- Pursuant to the provisions of the SEBI (LODR) Regulations, 2015 we hereby submit the voting results for the AGM held on 30th September 2026 1 October 2026 · BSE
- Pursuant to Regulation 30 & 44(3) of SEBI (LODR) Regulations , 2015 we hereby submit the Scrutinizer Report for the AGM held on 30th September, 2026 1 October 2026 · BSE
- We hereby submit the proceedings of the 35th Annual General Meeting of the Company held on Wednesday, 30th September, 2026 30 September 2026 · BSE
- Pursuant to the provisions of SEBI (LODR) Regulation ,2015 , We hereby submit the intimation towards Annual General Meeting of the Company scheduled to be held on Wednesday 30th September 2026 7 September 2026 · BSE
- Annual Report FY2025-26 (New) 7 September 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.